UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy

Kidney international, 2001-08, Vol.60 (2), p.777-785

2001

Volltextzugriff (PDF)

Trends in Automated Peritoneal Dialysis Prescriptions in a Large Dialysis Organization in the United States

Clinical journal of the American Society of Nephrology, 2024-06, Vol.19 (6), p.723

2024

Volltextzugriff (PDF)

Assessing the impact of transitional care units on dialysis patient outcomes: A multicenter, propensity score‐matched analysis

Hemodialysis international, 2023-04, Vol.27 (2), p.165-173

2023

Volltextzugriff (PDF)

The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis

Clinical kidney journal, 2022-01, Vol.15 (1), p.136-144

2022

Volltextzugriff (PDF)

Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension

EClinicalMedicine, 2024-09, Vol.75, p.102784, Article 102784

2024

Volltextzugriff (PDF)

Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy

American journal of kidney diseases, 2002-03, Vol.39 (3), p.556-570

2002

Volltextzugriff (PDF)

Challenges and Opportunities in Expanding Home Hemodialysis for 2025

Advances in chronic kidney disease, 2021-03, Vol.28 (2), p.129-135

2021

Volltextzugriff (PDF)

The Impact of Urgent Start Peritoneal Dialysis on Patient Outcomes: FR-PO502

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.460-460

2022

Volltextzugriff (PDF)

Patient Characteristics Associated With Attrition to In-Center From Home Hemodialysis Treatment: FR-PO512

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.462-462

2022

Volltextzugriff (PDF)

Medication Management with Antihypertensive Agents and Associations with Peritoneal Dialysis Technique Failure in a Large, Retrospective Incident Cohort: TH-PO319

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.180-180

2023

Volltextzugriff (PDF)

Immediate Start PD: A Single-Center Experience: PO0974

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.329-330

2021

Volltextzugriff (PDF)

Differences in Demographic and Clinical Outcomes Between Modalities for Patients 60 Days Post-Transitional Care Unit Initiation: SA-PO341

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.698-698

2022

Volltextzugriff (PDF)

Machine Learning-Driven Prediction of Peritoneal Dialysis Technique Failure: PO0971

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.329-329

2021

Volltextzugriff (PDF)

Forecasting the Distribution of Dialytic Modalities in the Era of Advancing American Kidney Health: FR-OR27

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.23-23

2020

Volltextzugriff (PDF)

Patient Characteristics and Frequency of Prescription (Rx) Alterations in Automated Peritoneal Dialysis (APD): PO1322

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.433-433

2020

Volltextzugriff (PDF)

Fluid-Related Risk Factors of Peritoneal Dialysis Technique Failure: FR-OR27

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.29-29

2021

Volltextzugriff (PDF)

Protective Association Found Between Peritoneal Dialysis Patients Prescribed Home Antibiotics Kits and In-Center Hemodialysis Transition: PO0994

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.335-336

2021

Volltextzugriff (PDF)

Length of Peritoneal Dialysis Training and Risk of Early Treatment Attrition: PO0969

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.328-328

2021

Volltextzugriff (PDF)

Consistency in Membrane Transport in Early and Later Peritoneal Equilibration Testing: FR-PO494

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.457-457

2022

Volltextzugriff (PDF)

Trends in Fever and Respiratory Illness in Hemodialysis Patients During the COVID-19 Pandemic: PO0713

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.262-262

2020

Volltextzugriff (PDF)

Morbidity and mortality in redefining adequacy of peritoneal dialysis: A step beyond the National Kidney Foundation dialysis outcomes quality initiative

American journal of kidney diseases, 1999-04, Vol.33 (4), p.617-632

1999

Volltextzugriff (PDF)

Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extensionResearch in context

EClinicalMedicine, 2024-09, Vol.75, p.102784

2024

Volltextzugriff (PDF)

Hybrid renal replacement modalities for the critically ill

Contributions to nephrology, 2001 (132), p.252-257

2001

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy

Trends in Automated Peritoneal Dialysis Prescriptions in a Large Dialysis Organization in the United States

Assessing the impact of transitional care units on dialysis patient outcomes: A multicenter, propensity score‐matched analysis

The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis

Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension

Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy

Challenges and Opportunities in Expanding Home Hemodialysis for 2025

The Impact of Urgent Start Peritoneal Dialysis on Patient Outcomes: FR-PO502

Patient Characteristics Associated With Attrition to In-Center From Home Hemodialysis Treatment: FR-PO512

Medication Management with Antihypertensive Agents and Associations with Peritoneal Dialysis Technique Failure in a Large, Retrospective Incident Cohort: TH-PO319

Immediate Start PD: A Single-Center Experience: PO0974

Differences in Demographic and Clinical Outcomes Between Modalities for Patients 60 Days Post-Transitional Care Unit Initiation: SA-PO341

Machine Learning-Driven Prediction of Peritoneal Dialysis Technique Failure: PO0971

Forecasting the Distribution of Dialytic Modalities in the Era of Advancing American Kidney Health: FR-OR27

Patient Characteristics and Frequency of Prescription (Rx) Alterations in Automated Peritoneal Dialysis (APD): PO1322

Fluid-Related Risk Factors of Peritoneal Dialysis Technique Failure: FR-OR27

Protective Association Found Between Peritoneal Dialysis Patients Prescribed Home Antibiotics Kits and In-Center Hemodialysis Transition: PO0994

Length of Peritoneal Dialysis Training and Risk of Early Treatment Attrition: PO0969

Consistency in Membrane Transport in Early and Later Peritoneal Equilibration Testing: FR-PO494

Trends in Fever and Respiratory Illness in Hemodialysis Patients During the COVID-19 Pandemic: PO0713

Morbidity and mortality in redefining adequacy of peritoneal dialysis: A step beyond the National Kidney Foundation dialysis outcomes quality initiative

Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extensionResearch in context

Hybrid renal replacement modalities for the critically ill

Suchergebnisse filtern